<DOC>
	<DOCNO>NCT02961062</DOCNO>
	<brief_summary>The purpose study determine SAF312 eye drop adequate safety efficacy profile justify clinical development treatment ocular pain associate corneal epithelial defect photorefractive keratectomy ( PRK ) surgery</brief_summary>
	<brief_title>Study SAF312 Eye Drop Treatment Eye Pain Following Photorefractive Keratectomy ( PRK ) Surgery</brief_title>
	<detailed_description />
	<mesh_term>Eye Pain</mesh_term>
	<criteria>Normal eye exam except refractive error baseline . Myopia exceed 4.00 Diopters ( sphere ) 3.00 diopter astigmatism , spherical equivalent high 4.50 , confirm manifest refraction baseline . Monocular patient ( include amblyopia ) best correct visual acuity score bad 20/80 ( Snellen ) 55 letter ( EDTRS ) , baseline . Any systemic ocular disease might affect wound healing ( severe rheumatoid arthritis diabetes history keloid formation ) history ocular trauma , uveitis , infection , inflammation 6 month prior baseline . Previous refractive corneal surgery ( LASIK , PRK , radial keratotomy , pterygium removal , corneal transplantation ) . Chronic pain etiology significant illness resolve within two ( 2 ) week prior initial dosing . Other inclusion exclusion criterion apply .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>ocular pain</keyword>
	<keyword>photorefractive keratectomy ( PRK )</keyword>
	<keyword>SAF312</keyword>
	<keyword>corneal epithelial defect</keyword>
</DOC>